| A2 | Low-level HIV-1 viral load predicts virologic failure in antiretroviral experienced individuals in Botswana | E-poster | Viral fitness, persistence and resistance |
| A2 | High resistance mutation to cART in HIV-1 exposed infected children and recent emergence of CRF02_AG variant in Bouar, a rural environment of Central African Republic | E-poster | Viral fitness, persistence and resistance |
| A3 | Implications of an interaction between HIV-1 Gag and the RNA interference pathway member Dicer''''''''' | E-poster | HIV biology (entry, recplicative cycle, tanscitional expression and regulation) |
| A3 | HIV-1 infection elicits virus-MLOs for intranuclear viral steps | E-poster | HIV biology (entry, recplicative cycle, tanscitional expression and regulation) |
| A5 | Extracellular vehicles carrying HIV-1 Nef induce trained immunity in myeloid cells | E-poster | Innate immunity |
| A5 | Robust anti-viral immune responses at the placenta during early gestation limit in utero HIV infection and replication | E-poster | Innate immunity |
| A6 | Isolation of SIVmac239 neutralizing antibodies with different specificities from infected rhesus macaques | E-poster | Humoral immunity (including broadly neutralizing antibodies) |
| A6 | Immunogenicity of a 2-dose human papillomavirus vaccination schedule in HIV-infected adolescents with immune reconstitution | E-poster | Humoral immunity (including broadly neutralizing antibodies) |
| A6 | Neutralizing antibody induction associated with a germline immunoglobulin gene polymorphism in rhesus macaques after neutralization-resistant SIVsmE543-3 infection | E-poster | Humoral immunity (including broadly neutralizing antibodies) |
| A7 | Daily immunological and virological variations in aviremic ART-treated people living with HIV | E-poster | Cellular immunity |